DASH, A., B. BLASIAK, Boguslaw TOMANEK, A. BANERJEE, S. TRUDEL, Peter LATTA and F.C.J.M. VAN VEGGEL. Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging. ACS Applied Nano Materials. Washington, D.C.: American Chemical Society, 2021, vol. 4, No 2, p. 1235-1242. ISSN 2574-0970. Available from: https://dx.doi.org/10.1021/acsanm.0c02848.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging
Authors DASH, A., B. BLASIAK, Boguslaw TOMANEK (616 Poland, belonging to the institution), A. BANERJEE, S. TRUDEL, Peter LATTA (703 Slovakia, guarantor, belonging to the institution) and F.C.J.M. VAN VEGGEL.
Edition ACS Applied Nano Materials, Washington, D.C. American Chemical Society, 2021, 2574-0970.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10305 Fluids and plasma physics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.140
RIV identification code RIV/00216224:14740/21:00124303
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1021/acsanm.0c02848
UT WoS 000624546800032
Keywords in English iron; nanoparticle; MRI; T-2 contrast; transverse relaxivity; magnetization; 3 T; 9.4 T
Tags CF MAFIL, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 26/2/2022 14:17.
Abstract
Iron nanoparticles (Fe NPs) produce negative contrast in magnetic resonance imaging (MRI) by shortening the transverse relaxation time (T-2) of water protons at tissue sites. The high sensitivity of Fe toward oxidation under ambient conditions has challenged and impeded the development of stable Fe NPs for bioapplications compared to iron oxide nanoparticles (IONPs). This article demonstrates the synthesis of three batches of fairly monodisperse (size dispersion, <10%), colloidal Fe NPs with inorganic core diameters of 15.2, 12.0, and 8.8 nm. The 15.2 nm Fe NPs show high stability against oxidation, beyond 5 months, when dispersed in chloroform and deionized water. Upon dispersion in deionized water, these NPs gradually develop an amorphous iron oxide shell. On the contrary, upon transfer into water, the smaller Fe NPs oxidize to amorphous iron oxide eventually. The 15.2 nm Fe NPs exhibit much stronger shortening of the T-2 relaxation time compared to the 12.0 and 8.8 nm Fe NPs at both high-field clinical 3 T and preclinical 9.4 T. The transverse relaxivity (r(2)) values of the 15.2 nm Fe NPs, based on per Fe ion concentration, were determined to be 167.9 mM(-1) s(-1) at 3 T and 236.4 mM(-1) s(-1) (higher than similarly sized IONPs) at 9.4 T. The respective r(2)/r(1) ratios of 280 and 788 are high for a T-2 contrast agent, although comprehensive MRI data for Fe NPs are not available in the literature for direct comparison. Fe NPs are promising MRI contrast agents for medical imaging.
Links
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 25/4/2024 18:35